Administration of α-syn/tau oligomers derived from PD patients to the brains of tau transgenic mice accelerated the formation of tau oligomers and induced more severe neuronal loss than did administration of tau oligomers alone [169]. The gene discussed is MAPT; the disease is Parkinson disease.